trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Women with high blood pressure should not take oral contraceptives after the age of 35.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that women with high blood pressure should not take oral contraceptives after the age of 35?

Yes. Medical guidelines and safety reviews consistently advise against the use of combined estrogen-containing oral contraceptives in women with hypertension, particularly as they age and face compounded cardiovascular risks.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked

The analysis

The claim aligns with established medical consensus and guidelines (such as WHO MEC criteria) regarding the contraindication of combined hormonal contraceptives in women with hypertension, especially over age 35 where arterial and thrombotic risks sharply increase. Papers 6, 9, and 11 explicitly support the need for risk-stratification and point out elevated cardiovascular or cerebrovascular risks when using hormonal contraceptives in hypertensive patients. There are no refuting papers.

Evidence for · 3
Cardiometabolic, Glycaemic, and Metabolic Safety of Hormonal Contraceptives in Women with Medical Conditions: A Systematic Review.
2026
Identifies hypertension as a key cardiometabolic risk factor that necessitates risk-stratified use of hormonal contraceptives due to potential adverse blood pressure and vascular changes.
Get citation
ED, E., L, N., O, O., SD, T., AH, U., EJ, A., & J, A. (2026). Cardiometabolic, Glycaemic, and Metabolic Safety of Hormonal Contraceptives in Women with Medical Conditions: A Systematic Review.. doi.org. https://doi.org/10.2147/ijwh.s601229

See more details
More for · 2
Cardiovascular Safety of Hormonal Contraception: Method-Specific Risks and Clinical Implications.
2026
Highlights hypertension as a major individual risk factor that strongly modifies and increases the cardiovascular and thrombotic risks of estrogen-containing combined hormonal contraceptives.
Get citation
I, W., A, B., A, P., L, M., & W, S. (2026). Cardiovascular Safety of Hormonal Contraception: Method-Specific Risks and Clinical Implications.. doi.org. https://doi.org/10.3390/medsci14020201

Safety and effectiveness of hormonal vs non-hormonal or no contraception in women with hypertension and future fertility desire: A broad-scope systematic review.
2026
Reviews safety data indicating that combined oral contraceptives pose elevated vascular risks, such as cerebrovascular disease, in hypertensive populations.
Get citation
N, L., K, E., OJ, V., BA, R., ÁJ, B., PA, G., MJ, H. B., & H, G. (2026). Safety and effectiveness of hormonal vs non-hormonal or no contraception in women with hypertension and future fertility desire: A broad-scope systematic review.. doi.org. https://doi.org/10.1371/journal.pone.0345959

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work